全球医疗包装市场：2024-2031年

医疗保健成本不断上涨和合规要求日益严格，正推动医疗和药品包装产业发生变革性成长。

本研究报告对全球医疗包装市场进行了全面分析，详细考察了2021年至2031年的区域细分、收入指标和材料趋势。透过检验历史数据并预测未来趋势，该报告提供了2025年至2031年的七年预测，其中2024年为基准年。

• 依产品类型：药品包装、医疗设备包装、医用输液袋
• 依材质分类：塑胶、玻璃、其他（包括金属、纸基材料和复合材料）
• 按地区划分：美洲、欧洲、亚太地区、中东、南亚和非洲（MEASA）

以美国为首的美洲地区凭藉其在先进药品和医疗设备製造领域的领先地位、完善的医疗基础设施以及对专业包装创新技术的广泛应用，构成了医疗保健包装的重要市场。欧洲拥有成熟的医疗保健包装市场，这主要得益于其严格的法规环境，强调病人安全和永续性。市场动态表明，医疗保健包装的普及速度正在加快，其中亚太地区是医疗保健包装成长最强劲的市场，中国、日本和新兴国家正在推动生产和消费的显着成长。

调查方法对每种包装类别、材料类型和地区的收入进行了深入分析，从而揭示了推动成长的因素和潜在挑战。预测基于预期的年复合成长率（CAGR），为市场发展趋势提供了策略视角。

收入和预测

基准年的预计收入为 1,048.7 亿美元，预计在 2024-2031 年的研究期间内，年复合成长率将达到 7.0%。

三大策略挑战对医疗包装产业的影响

变革性大趋势

原因

• 加州《无毒医疗设备法案》将于2030年前禁止使用含有邻苯二甲酸二(2-乙基己基)酯（DEHP）的静脉输液用品，该法案针对的材料占某些医疗设备总量的80%之多。 DEHP是塑化剂，可赋予聚氯乙烯（PVC）柔韧性，并与多种癌症相关，包括乳癌、肝癌、肺癌和睪丸癌。
• 医疗产品中邻苯二甲酸二(2-乙基己基)酯（DEHP）的含量可能高达40%（以重量计），这会污染患者使用的药物和输液。这对癌症患者构成特别严重的风险，因为DEHP会促进抗药性并降低化疗的疗效。欧盟透过医疗器材法规（MDR）和欧盟环境、法规及相关法规（REACH）制定了类似的法规，要求所有含有DEHP的医疗器材必须在2030年7月前获得批准或召回。

弗罗斯特的展望

• 未来三到五年内，儘管成本高昂，製造商仍需投资改造非PVC材料的生产线和检验流程。领导者正在开发能够去除邻苯二甲酸二辛酯（DEHP）、塑化剂和邻苯二甲酸酯的解决方案。
• 这些新产品透过优先排序和广泛检验展现了行业领先地位。随着加州禁令于2023年生效，早期市场定位表明，能够证明其永续性和安全性的合规公司可以避免市场中断，并透过合规性每年节省500万美元。

颠覆性技术

原因

• 製药业正迅速转向生物製药，生物製剂由源自活体生物的复杂蛋白质、抗体和活细胞生物来源。与小分子药物不同，生物製药对环境因素（例如温度、光照、湿度和表面相互作用）高度敏感，暴露于不利条件下会加速其降解，例如透过氧化、变性和聚集等机制。
• 传统包装材料可能缺乏所需的化合物或足够的阻隔性能。生技药品通常需要精确的低温运输管理（有时需要在超低温下进行），避免机械应力，并使用能最大限度减少蛋白质在表面吸附的材料，以确保其在整个保质期内的治疗效果。

弗罗斯特的展望

• 未来三到五年内，药品包装製造商需要开发专为生物製药优化的专用材料和输送系统。这将涉及大规模的研发工作，以充分发挥其固有的阻隔性能，抵御温度、湿度和机械应力，同时确保产品完整性。製造商需要专注于开发技术解决方案，以实现更清洁的生产过程。
• 生产灵活性至关重要：无尘室共享将成为新常态，使製造商能够实现产品组合多元化，以满足生技药品和製药领域多样化的客户需求，并实现设计和产能的灵活性。

地缘政治动盪

原因

• 地缘政治紧张局势加剧，贸易政策被武器化，为医疗包装製造商带来了前所未有的波动。主要国家间相对关税週期性波动，导致关键包装组件的关税高达336%，彻底颠覆了以往可预测的成本结构。
• 外交衝突往往在极短时间内引发对特种聚合物和药用级薄膜的突然限制。区域贸易集团的重组也围绕着政治联盟而非经济效率展开，导致原本一体化的供应链网络瓦解。

弗罗斯特的展望

未来两到三年，医疗包装製造商需要实施先进的贸易资讯系统，以预测关税变化并避免外交纠纷。企业应将製造地分散到不同的贸易区，并在适当情况下开发区域性生产方案，以规避贸易壁垒。

• 从可能受限的供应商策略性地采购必需材料，对于维持供应链和确保获得关键零件至关重要。

分析范围

这份全面的市场评估报告检视了医疗保健包装系统在三大关键领域的发展现状：药品包装、医疗设备包装和输液袋。报告提供了2021年至2031年（以2024年为基准年）的详细市场量化数据、成长预测和策略洞察。

本研究专门关注直接用于医疗保健应用的材料和加工后的包装组件，不包括辅助设备、机械和耗材。市场价值的计算是基于包装加工商层面，透过价值链分析，捕捉原材料转化为专业医疗保健包装解决方案的关键转折点。

该报告涵盖美洲、欧洲、中东和非洲、南亚（MEASA）以及亚太地区四大区域，分析了各区域的市场特征、法规环境和应用趋势。材料分析部分深入探讨了塑胶、玻璃、纸张、金属和复合材料的消费模式、永续性倡议和创新发展轨迹。

这份评估报告为医疗包装生态系统中的相关人员提供了可操作的信息，涵盖材料供应商、包装加工商、製药厂商、医疗设备厂商以及医疗服务提供者。该分析揭示了当前市场动态以及材料科学、法规遵循和患者安全交叉领域这一关键方向的新兴机会。

平均价格

每吨

成长驱动因素

• 医疗保健行业的成长和监管合规要求正在推动对药品包装的需求。
• 医疗设备产业的扩张为专业包装解决方案创造了持续的需求。
• 医疗保健支出不断增长以及製药厂数量增加将推动包装需求。
• 对具有增强功能的高附加价值药品包装材料的需求将推动收入成长。

成长抑制因素

• 严格的监管要求和冗长的检验过程对创新构成了重大障碍。
• 材料成本波动和供应链中断给可预测的生产和开发带来了挑战。
• 儘管优质包装解决方案具有性能优势，但由于医疗保健成本控制措施的限制，其应用受到限制。
• 平衡永续性目标与基本绩效要求的技术挑战；

目录

调查范围

• 分析范围
• 分割
• 地理覆盖范围

成长环境：医疗包装产业的转型

• 为什么成长变得越来越难？
• The Strategic Imperative 8（TM）
• 三大策略挑战对医疗包装产业的影响

医疗包装生态系统

• 价值链概览
• 价值链分析
• 竞争环境
• 主要竞争对手：医药包装
• 定义
• PVC的现状及其对医用输液袋产业的影响

医疗包装中的成长要素

• 成长指标
• 成长驱动因素
• 成长驱动因素分析
• 成长抑制因素
• 预测考量
• 收入预测
• 收入预测分析
• 按包装应用分類的收入预测
• 按包装应用分類的收入预测分析
• 按材料类型分類的收入预测
• 按材料类型分類的收入预测分析
• 按地区分類的收入预测
• 按地区分類的收入预测分析

药品包装的成长要素

• 功能概述
• 成长指标
• 收入预测
• 收入预测分析
• 按材料类型分類的收入预测
• 按材料类型分類的收入预测分析
• 按地区分類的收入预测
• 按地区分類的收入预测分析

医疗设备包装的成长要素

• 功能概述
• 成长指标
• 收入预测
• 收入预测分析
• 按材料类型分類的收入预测
• 按材料类型分類的收入预测分析
• 按地区分類的收入预测
• 按地区分類的收入预测分析

点滴袋成长要素

• 功能概述
• 成长指标
• 收入和预测
• 收入预测分析
• 按材料类型分類的收入预测
• 按材料类型分類的收入预测分析
• 按地区分類的收入预测
• 按地区分類的收入预测分析

医疗包装市场的成长机会

• 增长机会 1：敏感治疗药物的温控包装
• 成长机会 2：永续医疗保健包装解决方案
• 成长机会三：贸易不确定性下的策略性回流

附录与后续步骤

• 成长机会带来的益处和影响
• 下一步
• 附件清单
• 免责声明

Medical and Pharmaceutical Packaging is Experiencing Transformational Growth Due to Rising Healthcare Expenditure and Compliance Requirements

This comprehensive analysis of the global medical packaging market offers a detailed examination of regional segmentation, revenue metrics, and material trends, spanning the period from 2021 to 2031. By examining historical data and projecting future trends, the study provides a seven-year forecast from 2025 to 2031, with 2024 serving as the base year.

• By product category: Pharmaceutical Packaging, Medical Device Packaging, and Medical Fluid Bags
• By material: Plastics, Glass, and Others (including metals, paper-based materials, and composites)
• By region: Americas, Europe, Asia-Pacific (APAC), and the Middle East, South Asia, and Africa (MEASA)

The Americas region, with the United States at the forefront, represents a significant market for healthcare packaging, driven by the region's advanced pharmaceutical and medical device manufacturing, extensive healthcare infrastructure, and leadership in adopting specialized packaging innovations. Europe maintains a sophisticated healthcare packaging market, heavily influenced by the region's stringent regulatory environment, which focuses on patient safety and sustainability. MEASA shows accelerated growth in healthcare packaging adoption, while APAC represents the most dynamic growth market for healthcare packaging, with China, Japan, and emerging economies driving substantial expansion in production and consumption.

The study's methodology involves an in-depth analysis of the revenue for each packaging category, material type, and region, providing insights into the factors driving growth and potential challenges. The forecast is based on the anticipated compound annual growth rates (CAGRs), offering a strategic view of the market's evolution.

Revenue Forecast

The revenue estimate for the base year is $104.87 billion, with a CAGR of 7.0% for the study period from 2024 to 2031.

The Impact of the Top 3 Strategic Imperatives on the Medical Packaging Industry

Transformative Megatrends

Why

• The California Toxic-Free Medical Devices Act will ban DEHP-containing IV supplies by 2030, targeting materials that comprise up to 80% of some medical devices. DEHP, a plasticizer that makes PVC flexible, has been linked to multiple cancers, including breast, liver, lung, and testicular cancer.
• Medical products can contain up to 40% DEHP by weight, which can lead into medications and fluids administered to patients. This poses particular risks for cancer patients, as DEHP promotes drug resistance and reduces chemotherapy effectiveness. The EU has established similar regulations through MDR and REACH, requiring DEHP-containing devices to be either authorized or withdrawn by July 2030.

Frost Perspective

• Over the next 3 to 5 years, manufacturers must invest in redefining production lines and validation processes for non-PVC materials, despite significant costs. Forward-thinking companies are developing solutions that eliminate DEHP, plasticizers, and phthalates.
• These new products prioritize, extensive validation, and leadership. Although California's ban takes effect in 2023, early market positioning indicates that compliant companies, such as those that can demonstrate both sustainability and safety, will avoid disruption, saving $5 million annually by complying.

Disruptive Technologies

Why

• The pharmaceutical landscape is rapidly shifting toward biological drugs-complex proteins, antibodies, and living cells derived from living organisms. Unlike small-molecule drugs, biologics are highly sensitive to environmental factors (e.g., temperature, light, moisture, and surface interactions), which can lead to degradation through mechanisms such as oxidation, denaturation, and aggregation when exposed to unfavorable conditions.
• Traditional packaging materials may lack compounds or lack adequate barrier properties. Biologics often require precise cold chain management (sometimes at ultra-low temperatures), protection from mechanical stress, and materials that minimize protein adsorption at surfaces to ensure therapeutic efficacy throughout their shelf life.

Frost Perspective

• Over the next 3 to 5 years, pharmaceutical packaging manufacturers must develop specialized materials and delivery systems optimized for biological products. This includes the need for significant R&D to extricate essential barrier properties against temperature, moisture, and mechanical stress while ensuring product integrity. Manufacturers need to focus on advancing engineered solutions to cleaner production processes.
• Production flexibility will be essential. Cleanroom shares will be the new normal, where manufacturers diversify portfolios to accommodate diverse client needs across biologics and pharmaceuticals, enabling flexibility in design and capacity.

Geopolitical Chaos

Why

• Escalating geopolitical tensions are weaponizing trade policy, creating unprecedented volatility for medical packaging manufacturers. Relationally tariff cycles between major economies have imposed duties of up to 336% on key packaging components, transforming once-predictable cost structures.
• Diplomatic conflicts are triggering abrupt restrictions on specialized polymers and pharmaceutical-grade films, often with minimal notice. Regional trade blocs are realigning around political alliances rather than economic efficiency, fragmenting previously integrated supply networks.

Frost Perspective

In the next 2 to 3 years, medical packaging manufacturers must implement sophisticated trade intelligence systems to anticipate tariff changes and diplomatically navigate disruptions. Companies should diversify manufacturing footprints across different trade zones, developing regional production alternatives that circumvent suited trade barriers.

• Strategic sourcing of essential materials from potentially restricted sources will be crucial for maintaining supply chains and guaranteeing access to critical components.

Scope of Analysis

This comprehensive market assessment examines the evolving landscape of healthcare packaging systems across 3 critical segments: pharmaceutical packaging, medical device packaging, and fluid bags. The analysis provides detailed market quantification, growth forecasts, and strategic insights spanning from 2021 to 2031, with 2024 established as the base year.

The study focuses specifically on materials and converted packaging components used directly in healthcare applications, excluding secondary equipment, machinery, and ancillary supplies. Market values are calculated at the packaging converter level, as indicated in the value chain analysis, capturing the critical transformation point where raw materials are converted into specialized healthcare packaging solutions.

Geographic coverage encompasses 4 distinct regions-the Americas, Europe, the Middle East, Africa, South Asia (MEASA), and Asia-Pacific (APAC)-with each region analyzed for unique market characteristics, regulatory environments, and adoption trends. Material analysis provides granular insights into consumption patterns, sustainability initiatives, and innovation trajectories across plastic, glass, paper, metal, and composite substrates.

This assessment delivers actionable intelligence for stakeholders throughout the healthcare packaging ecosystem, from material suppliers and packaging converters to pharmaceutical manufacturers, medical device producers, and healthcare providers. The analysis illuminates both current market dynamics and emerging opportunities in this essential sector where material science, regulatory compliance, and patient safety intersect.

Average Price Representation

$ Per Ton

Growth Drivers

• Healthcare Industry Growth and Regulatory Compliance Drive Pharmaceutical Packaging Demand.
• Expansion in the Medical Device Industry Creates Sustained Demand for Specialized Packaging Solutions.
• Increased Healthcare Expenditure, Coupled With Rising Drug Manufacturing Facilities, Boosts Demand For Packaging.
• Demand for Value-added Pharmaceutical Packaging Materials With Enhanced Functionalities Propels Revenue Growth.

Growth Restraints

• Stringent Regulatory Requirements and Lengthy Validation Processes Create Significant Barriers to Innovation.
• Material Cost Volatility and Supply Chain Disruptions Challenge Predictable Manufacturing and Development.
• Healthcare Cost Containment Initiatives Limit Adoption of Premium Packaging Solutions Despite Performance Benefits.
• Technical Challenges in Balancing Sustainability Objectives With Essential Performance Requirements.

Table of Contents

Research Scope

• Scope of Analysis
• Segmentation
• Geographic Scope

Growth Environment: Transformation in the Medical Packaging Sector

• Why is it Increasingly Difficult to Grow?
• The Strategic Imperative 8™
• The Impact of the Top 3 Strategic Imperatives on the Medical Packaging Industry

Ecosystem in the Medical Packaging Sector

• Value Chain Overview
• Value Chain Analysis
• Competitive Environment
• Key Competitors-Pharmaceutical Packaging
• Definitions
• Current State of PVC and Its Impact on the Medical Fluid Bags Industry

Growth Generator in the Medical Packaging Sector

• Growth Metrics
• Growth Drivers
• Growth Driver Analysis
• Growth Restraints
• Forecast Considerations
• Revenue Forecast
• Revenue Forecast Analysis
• Revenue Forecast by Packaging Application
• Revenue Forecast Analysis by Packaging Application
• Revenue Forecast by Material Type
• Revenue Forecast Analysis by Material Type
• Revenue Forecast by Region
• Revenue Forecast Analysis by Region

Growth Generator in Pharmaceutical Packaging

• Characteristics and Overview
• Growth Metrics
• Revenue Forecast
• Revenue Forecast Analysis
• Revenue Forecast by Material Type
• Revenue Forecast Analysis by Material Type
• Revenue Forecast by Region
• Revenue Forecast Analysis by Region

Growth Generator in Medical Device Packaging

• Characteristics and Overview
• Growth Metrics
• Revenue Forecast
• Revenue Forecast Analysis
• Revenue Forecast by Material Type
• Revenue Forecast Analysis by Material Type
• Revenue Forecast by Region
• Revenue Forecast Analysis by Region

Growth Generator in Fluid Bags

• Characteristics and Overview
• Growth Metrics
• Revenue Forecast
• Revenue Forecast Analysis
• Revenue Forecast by Material Type
• Revenue Forecast Analysis by Material Type
• Revenue Forecast by Region
• Revenue Forecast Analysis by Region

Growth Opportunity Universe in Medical Packaging Market

• Growth Opportunity 1: Temperature-Controlled Packaging for Sensitive Therapeutics
• Growth Opportunity 2: Sustainable Healthcare Packaging Solutions
• Growth Opportunity 3: Strategic Reshoring Amid Trade Uncertainty

Appendix & Next Steps

• Benefits and Impacts of Growth Opportunities
• Next Steps
• List of Exhibits
• Legal Disclaimer